Diabetes and obesity drugs linked to thyroid cancer
This article comes from “naturalnews.com” The European Medicines Agency (EMA), the European Union’s (EU) version of the Food and Drug Administration (FDA), issued a drug safety signal this week about the elevated thyroid cancer risk associated with certain classes of pharmaceuticals for Type 2 diabetes and obesity. Semaglutide, the active ingredient found in the widely used anti-diabetes […]
Diabetes and obesity drugs linked to thyroid cancer Read More »









